<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Obstetric <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) seems to be a clinical subset of classical APS, for which the search for new markers is still challenging </plain></SENT>
<SENT sid="1" pm="."><plain>Soluble CD146 (sCD146) constitutes a circulating endothelial biomarker </plain></SENT>
<SENT sid="2" pm="."><plain>sCD146 is involved in the <z:mp ids='MP_0001845'>inflammatory response</z:mp> by promoting monocyte transmigration and displays chemotactic and angiogenic properties on endothelial cells </plain></SENT>
<SENT sid="3" pm="."><plain>Its detection in human sera reveals physiological variations related to age and sex </plain></SENT>
<SENT sid="4" pm="."><plain>A wide variation of sCD146 has been reported in several conditions </plain></SENT>
<SENT sid="5" pm="."><plain>In particular, sCD146 levels are significantly higher in women presenting a history of recurrent fetal losses </plain></SENT>
</text></document>